Delivery Order SPE2DB20D2104-SPE2DB25FMUAJ
- Not listed
- The Defense Logistics Agency awarded a $1,179.81 firm fixed price delivery order to AmerisourceBergen Drug Corp for Sulfamethoxazole-TMP DS tablets (500 count) on September 15, 2025, with completion targeted for September 16, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Sulfamethoxazole-Trimethoprim DS (a common antibiotic combination) under a firm fixed-price contract valued at $1,514.65. This non-set-aside award, executed on July 28, 2025, represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $2,353.59 to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Sulfamethoxazole-Trimethoprim DS tablets in quantities of 100 units. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 3, 2025. The award represents a continuation of AmerisourceBergen's pharmaceutical supply services to the federal government, with performance occurring at the company's corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for sulfamethoxazole-trimethoprim DS tablets (100-count bottles) valued at $4,627.09. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a non-set-aside competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract is executed as a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,906.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for sulfamethoxazole-trimethoprim double-strength tablets (500 count) with an ultimate completion date of September 22, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through...
- The Defense Logistics Agency awarded a $1,174.63 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for sulfamethoxazole-trimethoprim DS tablets (500 count). This is a firm fixed-price, competitively awarded contract with an ultimate completion date of August 22, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed at the contractor's Conshohocken,...
- The Defense Logistics Agency awarded a $1,287.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sulfamethoxazole-Trimethoprim (an antibiotic combination medication) in tablet form, with 90-count packaging. The contract, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a competitively awarded, non-set-aside transaction executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen will...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,465.11 to AmerisourceBergen Drug Corp for Sulfamethoxazole-TMP DS Tablet 100s, with an ultimate completion date of August 13, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed-price delivery order for pharmaceutical supplies to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Sulfamethoxazole-Trimethoprim DS tablets (100-count) on July 28, 2025, with a ceiling value of $1,514.65. This competitive, non-set-aside delivery order is classified as firm fixed price and is scheduled for completion by July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $9,411.39 to AmerisourceBergen Drug Corp for Sulfamethoxazole-Trimethoprim (Sulfa-TMP) DS 100-count tablets. This firm fixed-price delivery order, issued on August 8, 2025, represents a competitive award with an ultimate completion date of September 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal military and...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMUAJDelivery Order
The Defense Logistics Agency awarded a $2,480.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sulfamethoxazole-TMP DS tablets (100-count bottles) on June 25, 2025, with an ultimate completion date of June 26, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, supplying the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with a comprehensive range of medications and medical supplies. This delivery order fulfills military healthcare requirements for an antibiotic medication used to treat bacterial infections. AmerisourceBergen's extensive federal contract portfolio demonstrates consistent capability to meet DLA procurement needs through competitive award processes, with past deliveries spanning therapeutic domains including diabetes medications, neurological treatments, and pain management pharmaceuticals. The firm fixed-price structure and expedited completion timeline reflect the routine nature of pharmaceutical supply chain operations supporting military medical readiness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 6/25/25 |